BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 14527274)

  • 1. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans.
    Henderson B; Nair SP; Ward JM; Wilson M
    Annu Rev Microbiol; 2003; 57():29-55. PubMed ID: 14527274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
    Kachlany SC
    J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis.
    Akifusa S; Poole S; Lewthwaite J; Henderson B; Nair SP
    Infect Immun; 2001 Sep; 69(9):5925-30. PubMed ID: 11500475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis.
    Haubek D
    APMIS Suppl; 2010 Sep; (130):1-53. PubMed ID: 21214629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.
    Kachlany SC; Fine DH; Figurski DH
    Infect Immun; 2000 Nov; 68(11):6094-100. PubMed ID: 11035711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin.
    Kelk P; Abd H; Claesson R; Sandström G; Sjöstedt A; Johansson A
    Cell Death Dis; 2011 Mar; 2(3):e126. PubMed ID: 21390060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis.
    Haraszthy VI; Hariharan G; Tinoco EM; Cortelli JR; Lally ET; Davis E; Zambon JJ
    J Periodontol; 2000 Jun; 71(6):912-22. PubMed ID: 10914794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a quinol peroxidase mutant in Aggregatibacter actinomycetemcomitans.
    Takashima E; Konishi K
    FEMS Microbiol Lett; 2008 Sep; 286(1):66-70. PubMed ID: 18616592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
    Johansson A
    Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease.
    Tan KS; Song KP; Ong G
    J Periodontal Res; 2002 Aug; 37(4):268-72. PubMed ID: 12200970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pathogenesis of Aggregatibacter actinomycetemcomitans.
    Gholizadeh P; Pormohammad A; Eslami H; Shokouhi B; Fakhrzadeh V; Kafil HS
    Microb Pathog; 2017 Dec; 113():303-311. PubMed ID: 29117508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases.
    Wilson M; Henderson B
    FEMS Microbiol Rev; 1995 Dec; 17(4):365-79. PubMed ID: 8845187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis.
    Xynogala I; Volgina A; DiRienzo JM; Korostoff J
    Oral Microbiol Immunol; 2009 Apr; 24(2):116-23. PubMed ID: 19239638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Actinobacillus actinomycetemcomitans isolated from young Chinese aggressive periodontitis patients.
    Leung WK; Ngai VK; Yau JY; Cheung BP; Tsang PW; Corbet EF
    J Periodontal Res; 2005 Jun; 40(3):258-68. PubMed ID: 15853973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
    Crosby JA; Kachlany SC
    Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis.
    Johansson A; Buhlin K; Koski R; Gustafsson A
    Eur J Oral Sci; 2005 Jun; 113(3):197-202. PubMed ID: 15953243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.
    Balashova NV; Park DH; Patel JK; Figurski DH; Kachlany SC
    Infect Immun; 2007 Sep; 75(9):4490-7. PubMed ID: 17635874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serotype, leukotoxin gene type and lysogeny in Actinobacillus actinomycetemcomitans to periodontal disease status.
    Barretto Tinoco EM; Stevens R; Haubek D; Lai CH; Balachandran S; Preus H
    Eur J Oral Sci; 1997 Aug; 105(4):310-7. PubMed ID: 9298362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal diversity of Actinobacillus actinomycetemcomitans isolates from young adults with minimal periodontal disease.
    Macheleidt A; Müller HP; Eger T; Putzker M; Zöller L
    J Periodontal Res; 1999 May; 34(4):179-87. PubMed ID: 10444741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of genotypic variation in genes associated with virulence in Aggregatibacter actinomycetemcomitans clinical isolates.
    Pinheiro ET; Kawamoto D; Ota-Tsuzuki C; Almeida LR; Nunes AC; Longo PL; Wikstrom M; Mayer MP
    J Periodontal Res; 2011 Jun; 46(3):310-7. PubMed ID: 21338357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.